A study by scintigraphy to evaluate the effect of exenatide on gastric emptying in subjects with type 2 diabetes
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2014
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Amylin Pharmaceuticals
- 06 Feb 2013 Actual end date Jun 2005 added as reported by ClinicalTrials.gov.
- 28 Aug 2007 New trial record.